Axumin – A Breakthrough Discovery in the Fight Against Prostate Cancer

Axumin – A Breakthrough Discovery in the Fight Against Prostate Cancer

Now there’s Axumin (fluciclovine F 18), an FDA-approved positron emission tomography (PET) scan that works by analyzing the metabolic activity specific to prostate cancer. PET is a nuclear medicine imaging test that utilizes a tiny amount of radioactive material, called a radiotracer, that is attracted to tumor cells, enabling earlier cancer discovery than many other types of scans.

Why We Made the Switch to 3D Mammography

Why We Made the Switch to 3D Mammography

As the region’s only comprehensive women’s diagnostic services provider, RAO has replaced all 2D mammography equipment with FDA-approved 3D mammography, also known as tomosynthesis. Women naturally have questions about the difference, and we’re happy to explain the superiority of 3D mammography so you can feel confident about scheduling your routine breast cancer screening. 

In It to Win It – RAO Remains at the Front Lines of Early Detection

In It to Win It – RAO Remains at the Front Lines of Early Detection

RAO’s Women’s Imaging Center (WIC) and TimberRidge Imaging Center want to remind women to maintain a “Rosie” outlook on a riveting subject: early breast cancer detection. Most people know of the importance of finding breast cancer early, when it is most easily and successfully treated. But many don’t know about some of the more sophisticated technologies that arm our dedicated faction of breast imaging subspecialists.